Skip to content

Retina Microvascular Remodeling and Cognitive Function In Hypertension

Retina Microvascular Remodeling and Cognitive Function In Hypertension : Eyebrain

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02701855
Acronym
EYEBRAIN
Enrollment
160
Registered
2016-03-08
Start date
2014-10-31
Completion date
2017-12-31
Last updated
2016-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Mild Cognitive Impairment

Brief summary

This study aims to determine the relationships between retina micro-vascular remodeling and cognitive function in hypertensive patients. The study plans to enrol 160 patients (100 patients with mild cognitive impairment -MCI- and 60 without MCI).

Detailed description

Our project stands on physiopathological and cognitive angles, and is mainly based on the major role of large and small arteries elasticity on cognitive aging. It will benefit from the recent innovative accurate and non invasive techniques such as MRI for central large arteries and adaptative optics for retina arterioles imaging. Study population is the following: * 60 patients with hypertension and no MCI, * 50 patients with hypertension and stable MCI, without dementia * 50 patients with hypertension and progressive MCI, without dementia Every patients will perform a medical interview and examination, an MRI (brain + aorta), adaptative optics imaging, a cognitive tests and a blood test. Primary outcome is to determine the relationships between retina micro-vascular remodeling and cognitive function in this population.

Interventions

BEHAVIORALCognitive tests

Cognitive tests include: * The MMSE (Mini Mental State Examination) * Free and Cued Selective Recall Reminding Test (FCSRT). * Executive functions (fluencies, TMT A and B, span). * Tests of verbal fluency (literal and category) * Digit symbol substitution test or Wechsler adult intelligence scale (W.A.I.S) * The Clinical Dementia Rating Scale * The IADL scale evaluates autonomy. * Geriatric Depression screening Scale (GDS)

BIOLOGICALBlood test

A blood test will be performed in order to collect following parameters: Urea, BUN, Creatinine, Potassium, Sodium, hematocrit, hsCRP, NFS, Pq, LDL-C, HDL-C, Triglycerides, Lp(a), Lp-PLA2 as well as fasting glucose, HbA1C and microalbuminuria

RADIATIONBrain and aorta RMI

A magnetic resonance imaging exam will be performed at the Neuroimaging Research Center of the Pitié-Salpêtrière Hospital. This exam will be optimized to fit in 30 minutes. Indeed brain 3D T1 and T2 FLAIR imaging lasts 15 minutes while cine and velocity encoded imaging of the aorta lasts 15 minutes.

OTHERAdaptative optics

The retina adaptative optic imaging will be performed at the Unité de prevention des maladies cardiovasculaires Pitié Salpetrière Hospital. This exam lasts 10 minutes including patient positioning and imaging.

Sponsors

Fondation de Recherche sur l'Hypertension Artérielle
CollaboratorOTHER
Institute of Cardiometabolism and Nutrition, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Aged 65 or more 2. hypertension (BP ≥140/90 mmHg and/or antihypertensive treatment) 3. Signed informed consent by the patient 4. Sufficient mastery of the French language to perform neuropsychological tests

Exclusion criteria

1. Impossibility to visualize the retinal : severe cataract 2. Dementia (defined by MMSE\<20) 3. Clinical stroke 4. Severe or resistant Hypertension 5. Hypertension treated with more than 3 different pharmacological classes 6. any other disease that may interfere with the assessment of cognitive disorders (epilepsy, Parkinson's disease, major depression, schizophrenia, manic-depressive) 7. Enrolment in a therapeutic trial that could interfere with the main objective 8. Less than 4 years of formal education 9. Illiterate, unable to read, write or count 10. major physical problems that may interfere with the tests (sight, hearing, ...) 11. Short term life threatening disease 12. Non-affiliation to a healthcare system 13. Consent refusal 14. Contraindication to MRI including claustrophobia, metallic devices, pacemaker, mechanical valve implanted before 1985, and nursing, as well as technical contra-indication: patient diameter \> 70 cm or/and weight \> 250 kg

Design outcomes

Primary

MeasureTime frame
Relationships between retina micro-vascular remodeling and cognitive function in hypertensive patients.September 2017

Secondary

MeasureTime frame
• Associations between retina arteriolar remodelling and cerebrovascular lesions (infarcts, lacuna, and white matter lesions) quantified from MRI images.September 2017
• Associations between retina arteriolar remodelling and neurodegenerative lesions (hippocampus atrophy) quantified from MRI images.September 2017
• Associations between cognitive function and proximal aortic stiffness indices estimated from MRI images.September 2017
• Associations between proximal aortic stiffness and neurodegenerative lesions (hippocampus atrophy) quantified from MRI images.September 2017
• Associations between retina arteriolar remodelling and proximal aortic stiffness indices.September 2017
• Associations between proximal aortic stiffness and cerebrovascular lesions (infarcts, lacuna, and white matter lesions) quantified from MRI images.September 2017

Countries

France

Contacts

Primary ContactDavid Rosenbaum, Dr
david.rosenbaum@psl.aphp.fr01 42 17 57 74

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026